EP Patent

EP2813216A1 — Stabilized amorphous ticagrelor

Assigned to Zentiva KS · Expires 2014-12-17 · 11y expired

What this patent protects

Solid solution of ticagrelor molecularly dispersed within a polymer matrix formed by an ionic polymer in its solid state, characterized in that the ionic polymer is selected from hydroxypropyl methyl cellulose, polyvinylpyrrolidone or polyvinyl caprolactam-polyvinyl acetate-polye…

USPTO Abstract

Solid solution of ticagrelor molecularly dispersed within a polymer matrix formed by an ionic polymer in its solid state, characterized in that the ionic polymer is selected from hydroxypropyl methyl cellulose, polyvinylpyrrolidone or polyvinyl caprolactam-polyvinyl acetate-polyethyleneglycol.

Drugs covered by this patent

Patent Metadata

Patent number
EP2813216A1
Jurisdiction
EP
Classification
—
Expires
2014-12-17
Drug substance claim
No
Drug product claim
No
Assignee
Zentiva KS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.